511 related articles for article (PubMed ID: 26136751)
1. Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases.
Riedhammer C; Weissert R
Front Immunol; 2015; 6():322. PubMed ID: 26136751
[TBL] [Abstract][Full Text] [Related]
2. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
[TBL] [Abstract][Full Text] [Related]
3. Immunological aspects of demyelinating diseases.
Martin R; McFarland HF; McFarlin DE
Annu Rev Immunol; 1992; 10():153-87. PubMed ID: 1375472
[TBL] [Abstract][Full Text] [Related]
4. Autoreactive T and B cells in nervous system diseases.
Sun JB
Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
[TBL] [Abstract][Full Text] [Related]
5. Infections and autoimmune diseases.
Bach JF
J Autoimmun; 2005; 25 Suppl():74-80. PubMed ID: 16278064
[TBL] [Abstract][Full Text] [Related]
6. HLA-DR15-derived self-peptides are involved in increased autologous T cell proliferation in multiple sclerosis.
Mohme M; Hotz C; Stevanovic S; Binder T; Lee JH; Okoniewski M; Eiermann T; Sospedra M; Rammensee HG; Martin R
Brain; 2013 Jun; 136(Pt 6):1783-98. PubMed ID: 23739916
[TBL] [Abstract][Full Text] [Related]
7. Multiple sclerosis-associated CLEC16A controls HLA class II expression via late endosome biogenesis.
van Luijn MM; Kreft KL; Jongsma ML; Mes SW; Wierenga-Wolf AF; van Meurs M; Melief MJ; der Kant Rv; Janssen L; Janssen H; Tan R; Priatel JJ; Neefjes J; Laman JD; Hintzen RQ
Brain; 2015 Jun; 138(Pt 6):1531-47. PubMed ID: 25823473
[TBL] [Abstract][Full Text] [Related]
8. The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosis.
Kaushansky N; Eisenstein M; Zilkha-Falb R; Ben-Nun A
Autoimmun Rev; 2010 Feb; 9(4):233-6. PubMed ID: 19683076
[TBL] [Abstract][Full Text] [Related]
9. HLA class II polymorphism: implications for genetic susceptibility to autoimmune disease.
Gregersen PK
Lab Invest; 1989 Jul; 61(1):5-19. PubMed ID: 2664347
[TBL] [Abstract][Full Text] [Related]
10. Adaptive Immunity Is the Key to the Understanding of Autoimmune and Paraneoplastic Inflammatory Central Nervous System Disorders.
Weissert R
Front Immunol; 2017; 8():336. PubMed ID: 28386263
[TBL] [Abstract][Full Text] [Related]
11. HLA restriction and TCR usage of T lymphocytes specific for a novel candidate autoantigen, X2 MBP, in multiple sclerosis.
Voskuhl RR; Robinson ED; Segal BM; Tranquill L; Camphausen K; Albert PS; Richert JR; McFarland HF
J Immunol; 1994 Nov; 153(10):4834-44. PubMed ID: 7525716
[TBL] [Abstract][Full Text] [Related]
12. Multiple sclerosis: MHC associations and therapeutic implications.
Holmes S; Friese MA; Siebold C; Jones EY; Bell J; Fugger L
Expert Rev Mol Med; 2005 Feb; 7(3):1-17. PubMed ID: 15710050
[TBL] [Abstract][Full Text] [Related]
13. The immunology of multiple sclerosis: disease mechanisms and therapeutic targets.
Holmøy T
Minerva Med; 2008 Apr; 99(2):119-40. PubMed ID: 18431322
[TBL] [Abstract][Full Text] [Related]
14. Antigen presentation in uveitis.
Prasad SA; Gregerson DS
Eye (Lond); 1997; 11 ( Pt 2)():176-82. PubMed ID: 9349409
[TBL] [Abstract][Full Text] [Related]
15. [The role of hereditary and environmental factors in autoimmune thyroid diseases].
Balázs C
Orv Hetil; 2012 Jul; 153(26):1013-22. PubMed ID: 22735372
[TBL] [Abstract][Full Text] [Related]
16. Tolerization of an established alphaB-crystallin-reactive T-cell response by intravenous antigen.
Verbeek R; van der Mark K; Wawrousek EF; Plomp AC; van Noort JM
Immunology; 2007 Jul; 121(3):416-26. PubMed ID: 17386078
[TBL] [Abstract][Full Text] [Related]
17. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis.
Ota K; Matsui M; Milford EL; Mackin GA; Weiner HL; Hafler DA
Nature; 1990 Jul; 346(6280):183-7. PubMed ID: 1694970
[TBL] [Abstract][Full Text] [Related]
18. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.
Zozulya AL; Wiendl H
Hum Immunol; 2008 Nov; 69(11):797-804. PubMed ID: 18723060
[TBL] [Abstract][Full Text] [Related]
19. Multiantigen/multiepitope-directed immune-specific suppression of "complex autoimmune encephalomyelitis" by a novel protein product of a synthetic gene.
Zhong MC; Kerlero de Rosbo N; Ben-Nun A
J Clin Invest; 2002 Jul; 110(1):81-90. PubMed ID: 12093891
[TBL] [Abstract][Full Text] [Related]
20. HLA associated genetic predisposition to autoimmune diseases: Genes involved and possible mechanisms.
Thorsby E; Lie BA
Transpl Immunol; 2005 Aug; 14(3-4):175-82. PubMed ID: 15982560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
